Edition:
United States

Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

122.02USD
7 Dec 2016
Change (% chg)

$-4.38 (-3.47%)
Prev Close
$126.40
Open
$123.80
Day's High
$124.49
Day's Low
$119.37
Volume
2,511,692
Avg. Vol
1,341,961
52-wk High
$196.47
52-wk Low
$119.37

ILMN.O

Chart for ILMN.O

About

Illumina, Inc. (Illumina) offers sequencing and array-based solutions for genetic analysis. The Company's products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. The Company's customers include genomic research centers, academic institutions,... (more)

Overall

Beta: 1.18
Market Cap(Mil.): $18,568.16
Shares Outstanding(Mil.): 146.90
Dividend: --
Yield (%): --

Financials

  ILMN.O Industry Sector
P/E (TTM): 42.26 55.81 30.77
EPS (TTM): 2.99 -- --
ROI: 12.83 7.05 15.23
ROE: 21.23 10.65 16.56

Illumina wins dismissal of Scripps Institute patent lawsuit

A federal judge in San Diego has dismissed a lawsuit by the non-profit Scripps Research Institute accusing Illumina Inc of infringing a patent related to a type of genetic analysis tool.

Nov 23 2016

BRIEF-Illumina Q3 GAAP earnings per share $0.87

* Says continues to project Q4 revenue to be flat to slightly up compared to Q3

Nov 01 2016

BRIEF-German court issues preliminary injunction against Amedes Fetalis test

* German court issues preliminary injunction against Amedes Fetalis test for infringement of non-invasive prenatal screening patent

Oct 24 2016

BRIEF-Illumina announces preliminary revenue for Q3

* Illumina announces preliminary revenue for third quarter of fiscal year 2016

Oct 10 2016

BRIEF-Illumina increases size of board from eight to nine members

* Effective as of july 27, 2016, board of directors increased size of board from eight to nine members - sec filing Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jul 28 2016

BRIEF-Illumina names Philip Schiller to its board

* Says Schiller is currently Apple's senior vice president of worldwide marketing

Jul 28 2016

BRIEF-Illumina reports Q2 adj. earnings $0.86/shr

* Illumina reports financial results for second quarter of fiscal year 2016

Jul 26 2016

BRIEF-Enzo Biochem says Enzo Life Sciences reached settlement with Illumina that included payment of $21 mln to Enzo

* Co's unit, Enzo Life Sciences, has reached and finalized a settlement with Illumina that included a payment of $21 million to enzo

Jul 07 2016

BRIEF-Natera and Illumina extend supply agreement, broaden existing partnership to include oncology field

* Natera and Illumina extend supply agreement, broaden existing partnership to include oncology field Source text for Eikon: Further company coverage: )

Jun 29 2016

BRIEF-Natera, Illumina Inc enter 3rd amendment to supply agreement dated August 16, 2013

* On June 8, 2016, co and Illumina Inc entered into third amendment to a supply agreement dated August 16, 2013

Jun 13 2016

Earnings vs. Estimates